Pharmaceuticals Market Research Reports

Alzheimer's: Disease Inights and Market Forecasts to 2024 - Product Thumbnail Image

Alzheimer's: Disease Inights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
Idiopathic Pulmonary Fibrosis: Disease Inights and Market Forecasts to 2024 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis: Disease Inights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
Parkinson's: Disease Inights and Market Forecasts to 2024 - Product Thumbnail Image

Parkinson's: Disease Inights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
COPD: Disease Inights and Market Forecasts to 2024 - Product Thumbnail Image

COPD: Disease Inights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

  • Report
  • 148 Pages
From
HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies - Product Thumbnail Image

HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies

  • Report
  • 92 Pages
From
Schizophrenia: Disease Inights and Market Forecasts to 2024 - Product Thumbnail Image

Schizophrenia: Disease Inights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs - Product Thumbnail Image

Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs

  • Report
  • 181 Pages
From
Attention Deficit Hyperactivity Disorder (ADHD): Disease Insights and Market Forecasts to 2024 - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD): Disease Insights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
Epiomic Epidemiology Series: Migraine Forecast In 12 Major Markets 2018-2028 - Product Thumbnail Image

Epiomic Epidemiology Series: Migraine Forecast In 12 Major Markets 2018-2028

  • Report
  • 54 Pages
From
Laboratory Informatics Market By Product (LIMS, ELN, LES, EDC, ECM, CDMS, SDMS), Component (Services, Software), Delivery, End User (Pharma, Biotech, MDx, Biobank, CRO, F&B, Oil, Gas, Petroleum, Chemical) – Global Forecast To 2023 - Product Thumbnail Image

Laboratory Informatics Market By Product (LIMS, ELN, LES, EDC, ECM, CDMS, SDMS), Component (Services, Software), Delivery, End User (Pharma, Biotech, MDx, Biobank, CRO, F&B, Oil, Gas, Petroleum, Chemical) – Global Forecast To 2023

  • Report
  • 188 Pages
From
Migraine - A Detailed Overview - Product Thumbnail Image

Migraine - A Detailed Overview

  • Report
  • 125 Pages
Head and Neck Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Immunotherapies and Increasing Prevalence to Drive the Market - Product Thumbnail Image

Head and Neck Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Immunotherapies and Increasing Prevalence to Drive the Market

  • Report
  • 155 Pages
From
Global Genetic Disorders Drugs Market to 2023 - A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease - Product Thumbnail Image

Global Genetic Disorders Drugs Market to 2023 - A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease

  • Report
  • 160 Pages
From
Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential - Product Thumbnail Image

Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential

  • Report
  • 199 Pages
From
COPD Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies - Product Thumbnail Image

COPD Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies

  • Report
  • 120 Pages
From
Global Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape - Product Thumbnail Image

Global Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape

  • Report
  • 228 Pages
From
Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market - Product Thumbnail Image

Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market

  • Report
  • 91 Pages
From
Lower Urinary Tract Symptoms Forecast in 12 Major Markets 2018-2028 - Product Thumbnail Image

Lower Urinary Tract Symptoms Forecast in 12 Major Markets 2018-2028

  • Report
  • 52 Pages
From
Global Sports Nutrition and High Energy Supplements Market 2017-2022 - Product Thumbnail Image

Global Sports Nutrition and High Energy Supplements Market 2017-2022

  • Report
  • 238 Pages
From
Loading Indicator
adroll